Clinical Trials

430 enrolled

Solid Tumours

NCT02934568 2026-04-16

Ribociclib (LEE011) Rollover Study for Continued Access

22 enrolled

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

NCT03736889 2026-04-15

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

200 enrolled

MSI-H/dMMR Solid Tumors

NCT04886271 2026-04-15

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT06619509 2026-04-14

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

90 enrolled

Solid Tumours

NCT06679634 2026-04-14

Retinoblastoma Phase II Expanded Access Clinical Trial

30 enrolled

Retinoblastoma

NCT07172919 2026-04-09

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

14 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumors

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT07359820 2026-04-07

ReFocus202

30 enrolled

FGFR2 Gene Fusion/Rearrangement

NCT04911907 2026-04-03

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

126 enrolled

Solid Tumor

NCT04589845 2026-04-02

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

920 enrolled 2 FDA

Phase 2 Not yet recruiting

Solid Tumors

NCT07390383 2026-04-01

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT04891198 2026-03-25

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

126 enrolled

Solid Tumor

NCT07032077 2026-03-20

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

100 enrolled

Solid Tumors

NCT04083976 2026-03-19

RAGNAR

316 enrolled 15 charts

Advanced Solid Tumor

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Advanced Solid Tumour

NCT07196644 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

125 enrolled

Solid Tumors Harboring MET Amplification

NCT07331155 2026-03-09

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

110 enrolled

Advanced Solid Tumour

NCT01843374 2026-03-05

Tremelimumab

571 enrolled 19 charts

Diabetes Mellitus, Insulin-Dependent, 12, Mesothelioma, Malignant

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

20 enrolled

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT07246863 2026-03-04

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

131 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT07028281 2026-03-03

A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

120 enrolled

Malignant Solid Tumors

NCT07098988 2026-02-27

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

107 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT05631262 2026-02-13

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

321 enrolled

Selected Subjects With Advanced Solid Tumors

NCT06783647 2026-02-12

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

230 enrolled

Advanced Solid Tumour

NCT05661578 2026-02-09

SKYSCRAPER-11

64 enrolled

PD-L1-selected Solid Tumors

NCT07387081 2026-02-04

Phase II Study of LM-24C5

130 enrolled

Advanced Solid Tumor Cancer

NCT04999969 2026-02-03

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

126 enrolled 30 charts

Locally Advanced or Metastatic Solid Tumours

NCT05419375 2026-02-03

Screening Study for Participants With Malignant Tumors

470 enrolled

Solid Tumors

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

16 enrolled 16 charts

Solid Tumor, Adult

NCT05136677 2026-01-23

CheckMate 6DW

102 enrolled

Mesothelioma, Malignant

NCT04617054 2026-01-21

Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion

14 enrolled

Solid Tumor

NCT07268040 2026-01-12

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

400 enrolled

Malignant Solid Tumors

NCT07321574 2026-01-07

ABP1011T-03

110 enrolled

SCLC, Extensive Stage

NCT06927687 2026-01-05

Study of ZG005 in Patients With Advanced Solid Tumors

100 enrolled

Advanced Solid Tumor

NCT07028268 2025-12-31

A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

210 enrolled

For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors

NCT07003321 2025-12-18

A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer

120 enrolled

Solid Tumor

NCT07130383 2025-11-18

A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

BreastOther solid neoplasm

210 enrolled

Advanced Breast Cancer

NCT05119907 2025-11-17

Study of Sacituzumab Govitecan in Patients With Solid Tumor

53 enrolled

Solid Tumor

NCT02060188 2025-11-06

CheckMate142

385 enrolled 17 charts 4 FDA

GastrointestinalOther solid neoplasm

Microsatellite Unstable Colorectal Cancer

NCT05642780 2025-10-14

SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors

240 enrolled

Solid Tumor

NCT06660654 2025-10-14

A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

200 enrolled

Advanced Solid Tumor

NCT04914897 2025-10-02

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

106 enrolled 21 charts

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02628067 2025-09-22

KEYNOTE 158

EndocrineGastrointestinalGynecologicHead & NeckNETOther solid neoplasmThoracic

1,609 enrolled 9 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Anus Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Uterine Cervical Neoplasms, Mesothelioma, Parotid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Microsatellite Instability, Small Cell Lung Carcinoma

NCT06947291 2025-09-08

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

GastrointestinalOther solid neoplasm

350 enrolled

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT05014828 2025-08-24

To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors

58 enrolled 16 charts

Advanced Solid Tumor

NCT05208177 2025-08-22

A Study of SHR-1802 in Patients With Advanced Solid Tumor

25 enrolled

Advanced Solid Tumor

NCT05563272 2025-07-10

STARBURST

CNSGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

11 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT01197885 2025-06-13

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

54 enrolled